Olongapo to start COVID-19 vaccination for minors on November 4 | Inquirer News

Olongapo to start COVID-19 vaccination for minors on November 4

Olongapo City is preparing to vaccinate against COVID-19 eligible minors who are 12 to 17 years old. The city’s pilot vaccination for the age group will begin on Nov. 4 (Photo courtesy of Olongapo City Public Information Office)

OLONGAPO CITY—The city will start the COVID-19 vaccination for minors who are 12 to 17 years old starting November 4, the local health office said on Friday, Oct. 29.

A total of 150 minors who have comorbidities will be inoculated as part of the launching of the mass vaccination, which will continue on November 5 and November 8-12.

ADVERTISEMENT

According to the city government, the vaccination will be held at the James L. Gordon Memorial Hospital.

FEATURED STORIES

The online registration has already started in the city for the pilot immunization of young residents.

So far, at least 143, 963 eligible residents in the city have received either the first or second dose of the vaccine against the viral disease.

The city targets to inoculate 70 percent or 182,000 of its 260,000-population to achieve herd immunity against COVID-19.

JPV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, COVID-19, Olongapo City, Vaccination

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.